![InvestingPro's Mid-Year Sale: Save up to 60% with Discount Code INVPRODEAL](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEJ6G08L_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.980 | 4.980 | 0.000 |
Stocks | 94.820 | 94.820 | 0.000 |
Bonds | 0.200 | 0.200 | 0.000 |
Convertible | 0.010 | 0.010 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.440 | 19.288 |
Price to Book | 3.586 | 3.936 |
Price to Sales | 4.366 | 4.733 |
Price to Cash Flow | 13.884 | 15.506 |
Dividend Yield | 0.830 | 0.502 |
5 Years Earnings Growth | 6.787 | 11.527 |
Number of long holdings: 142
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 8.88 | 472.51 | -0.31% | |
Regeneron Pharma | US75886F1075 | 7.17 | 1,050.86 | -1.71% | |
Amgen | US0311621009 | 6.96 | 313.69 | +0.28% | |
Gilead | US3755581036 | 6.60 | 68.83 | -0.69% | |
Alnylam | US02043Q1076 | 3.08 | 247.00 | +0.75% | |
Moderna | US60770K1079 | 2.95 | 121.18 | -1.04% | |
Sanofi ADR | US80105N1054 | 2.68 | 48.08 | -0.52% | |
Biomarin Pharma | US09061G1013 | 2.63 | 83.50 | -2.05% | |
Biogen | US09062X1037 | 2.54 | 228.72 | +1.90% | |
Illumina | US4523271090 | 2.12 | 106.46 | +0.74% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Deka Globale Aktien LowRisk CF A | 3.5B | 4.76 | 6.81 | 8.42 | ||
Deka Nachhaltigkeit Aktien CF A | 1.51B | 9.06 | 6.42 | 8.86 | ||
Deka Globale Aktien LowRisk PB A | 1.25B | 4.91 | 7.18 | 8.80 | ||
Deka Globale Aktien LowRisk I A | 757.76M | 4.93 | 7.23 | 8.84 | ||
DekaStruktur: Chance | 717.05M | 7.69 | 2.99 | 4.89 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review